Literature DB >> 12482610

p80 ROKalpha binding protein is a novel splice variant of CRMP-1 which associates with CRMP-2 and modulates RhoA-induced neuronal morphology.

Thomas Leung1, Yvonne Ng, Albert Cheong, Chong Han Ng, Ivan Tan, Christine Hall, Louis Lim.   

Abstract

Using antibody against the Rho binding domain of ROKalpha, two neuronal phosphoproteins of 62 and 80 kDa were co-immunoprecipitated from brain extracts. Peptide analysis revealed their identity as collapsin response mediator proteins (CRMPs); p62 was CRMP-2 whereas p80 was a novel splice form of CRMP-1 with an extended N-terminus. p80 CRMP-1 was able to complex with CRMP-2, suggesting that p80 CRMP-1 and CRMP-2 form oligomers. CRMP-2 was the major substrate of ROK. p80 CRMP-1 interacted with the kinase domain of ROKalpha, resulting in inhibition of the catalytic activity towards other substrates. Over-expression of p80 CRMP-1 and CRMP-2 together counteracted the effects of RhoA on neurite retraction, an effect enhanced by mutation of the ROK phosphorylation site in CRMP-2. p80 CRMP-1 and CRMP-2 may be modulators of RhoA-dependent signaling, through interaction with and regulation of ROKalpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482610     DOI: 10.1016/s0014-5793(02)03736-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

Review 1.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

2.  RhoA inactivation prevents photoreceptor axon retraction in an in vitro model of acute retinal detachment.

Authors:  Aurora Maria Fontainhas; Ellen Townes-Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

3.  Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Authors:  José M A Moreira; Teresa Cabezón; Irina Gromova; Pavel Gromov; Vera Timmermans-Wielenga; Isidro Machado; Antonio Llombart-Bosch; Niels Kroman; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2010-10-08       Impact factor: 6.603

Review 4.  CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.

Authors:  T T Quach; J Honnorat; P E Kolattukudy; R Khanna; A M Duchemin
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

5.  The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1.

Authors:  Szu-Hua Pan; Yu-Chih Chao; Pei-Fang Hung; Hsuan-Yu Chen; Shuenn-Chen Yang; Yih-Leong Chang; Chen-Tu Wu; Cheng-Chi Chang; Wen-Lung Wang; Wing-Kai Chan; Yi-Ying Wu; Ting-Fang Che; Lu-Kai Wang; Chien-Yu Lin; Yung-Chie Lee; Min-Liang Kuo; Chau-Hwang Lee; Jeremy J W Chen; Tse-Ming Hong; Pan-Chyr Yang
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

6.  Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.

Authors:  Matthew Brown; Tom Jacobs; Britta Eickholt; Giovanna Ferrari; Mabel Teo; Clinton Monfries; Robert Z Qi; Thomas Leung; Louis Lim; Christine Hall
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

7.  CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cells.

Authors:  Changlin Li; Haixia Xu; Lin Xiao; Haizhou Zhu; Guoan Zhang; Wei Wei; Kaizhi Li; Xiande Cao; Daqing Shen; Jeffrey Holzbeierlein; Benyi Li
Journal:  Cancer Biol Ther       Date:  2018-08-06       Impact factor: 4.742

8.  Proteomic analysis reveals Hrs ubiquitin-interacting motif-mediated ubiquitin signaling in multiple cellular processes.

Authors:  Julia W Pridgeon; Elizabeth A Webber; Di Sha; Lian Li; Lih-Shen Chin
Journal:  FEBS J       Date:  2009-01       Impact factor: 5.542

9.  Glial cell line-derived neurotrophic factor and neurturin inhibit neurite outgrowth and activate RhoA through GFR alpha 2b, an alternatively spliced isoform of GFR alpha 2.

Authors:  Li Foong Yoong; Heng-Phon Too
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

10.  Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders.

Authors:  Rajesh Khanna; Sarah M Wilson; Joel M Brittain; Jill Weimer; Rukhsana Sultana; Allan Butterfield; Kenneth Hensley
Journal:  Future Neurol       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.